1 with a SO 3 H:COOH ratio of 2.86 and molecular mass of 23.2 kDa, was the most potent anti-HIV-1 compound (EC 50 0.04 µg/ml). A second oversulphated dermatan, with a SO 3 H:COOH ratio of 2.40 and molecular mass of 25 kDa, displayed the highest activity against HSV-1 (EC 50 0.01 µg/ml). An oversulphated chondroitin, with a SO 3 H:COOH ratio of 2.80 and molecular mass of 17.3 kDa, was the strongest anti-HCMV agent (EC 50 0.4 µg/ml). In view of the absence of the side-effects typical of heparin-like compounds, a combination of these derivatives could have therapeutic potential.
The inhibitory effect of polyanionic substances on the replication of herpes simplex virus (HSV) and other viruses was first reported more than 30 years ago (Nahmias & Kibrick, 1964) . After the discovery that AIDS is caused by a retrovirus lentivirus, human immunodeficiency virus (HIV), interest in the antiviral activity of these kinds of substances was renewed (Ito et al., 1987) . A number of sulphated polysaccharides, including first of all heparin (Figure 1 ), but also pentosan sulphate and lentinan sulphate, were then found to be potent and selective inhibitors of HIV-1 replication in cell culture, hindering the adsorption of the viral envelope glycoproteins onto components of the plasmatic cell membrane (Baba et al., 1988a,b) .
The activity spectrum of the sulphated polysaccharides, as well as that of several non-glycosidic polyanions, was shown to extend to various other enveloped viruses (Schols et al., 1990; Leydet et al., 1996) .
Studies were also performed ( Jurkiewicz et al., 1989) on the in vitro anti-HIV-1 activity of natural chondroitin sulphate (CS; copolymers mainly composed of D-glucuronic acid connected 1-3 with either N-acetylgalactosamine 4-or 6-sulphate), dermatan sulphate (DS; copolymers mainly composed of L-iduronic acid connected 1-3 with N-acetylgalactosamine 4-sulphate), both polysaccharides generically named chondroitins ( Figure 1 ) and on fractions of chemically polysulphated CS of molecular mass in the range of 6-30 kDa, for which the extent of oversulphation was not assessed. Oversulphation of chondroitins makes them similar to heparin (copolymer mainly composed of L-iduronic acid 2sulphate and D-glucosamine N-6-disulphate). This confers antiviral properties similar to those found in heparin itself, but includes the possibility of acquiring the anti-haemocoagulative side-effects which are typical of heparin-like compounds, and which can limit their therapeutic use.
This paper presents a new study on the evaluation of HIV-1) , the aetiological agent of AIDS, and against herpes simplex virus type 1 and human cytomegalovirus, two agents responsible for opportunistic infections in HIV-infected people. The oversulphated derivatives displayed an increase in activity ranging from one to four orders of magnitude against the three viruses, as compared to the natural parent compounds (SO 3 H:COOH, ratio approx. 1). The antiviral activity of these polyanions appears to be favoured by a high degree of sulphation and a high molecular mass. An oversulphated dermatan,
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the antiviral potential of chemically oversulphated derivatives of natural CS and DS fractions. Oversulphated DS in particular have never before been considered. All fractions were characterized for molecular mass and sulphation index and were analysed for their potential side-effects on the haemocoagulative system. They were then tested against HIV-1, an enveloped RNA virus, and against HSV-1 and human cytomegalovirus (HCMV ), two enveloped DNA viruses.
Materials and Methods: Chemistry
Natural CS samples were derived from bovine intestinal mucose (1) and shark cartilage (3 and 5). Oversulphated CS samples (2, 4, 6-8) were obtained by the rather drastic oversulphation of the triethylammonium salt of the parent compounds dissolved in N,N-dimethylformamide (DMF) and added to chlorosulphonic acid 1.5:1 (6), 3:1 (4, 7, 8), 6:1 (2) with respect to the calculated number of disaccharides (Wolfrom et al., 1953) . The solution was heated at 50°C for 1 h and the raw product was neutralized with sodium acetate, precipitated with cold acetone, filtered, dis-solved in water, dialysed against water, concentrated by reverse osmosis and precipitated by adding two volumes of methanol. Natural DS samples came from bovine intestinal mucose (9) and porcine mucose (11). Oversulphated DS samples (10 and 12-14) were obtained by oversulphation, under mild conditions, by suspension in DMF and treatment, for 5 h, with adducts of triethylamine-sulphurtrioxide in a 3 : 1 (12,13) or 7 : 1 (10,14) excess by weight (Whistler & Spencer 1964) . The suspension was then diluted with water, adjusted to pH 6.5 and filtered. The filtrate was dialysed against water and the product was then concentrated by reverse osmosis and precipitated by adding two volumes of methanol. Natural samples of CS and DS were proved to be free from heparin contamination by electrophoresis on TITAN III plates (Helena Labs, Beaumont, Tex., USA). Dextran sulphate was purchasedfrom Sigma. Heparin sodium salt was derived from bovine intestinal mucose. The molecular masses of the examined compounds were determined by HPSEC against relative molecular weight standard compounds on a third order polynomial calibration curve (Volpi et al., 1992) . The SO 3 H:COOH ratio was determined by potentiometry with a Metrohm 682 titroprocessor (Volpi et al., 1992) .
As for the position of the additional sulphate groups, the regioselectivity of chemical sulphation is expected to be in the order C-6 of N-acetylgalactosamine, then C-2 or C-3 of uronic acid, C-4 of N-acetylgalactosamine (Nagasawa et al., 1986) and can be assessed according to 1 H-NMR (Bossennec et al., 1990 ) and 13 C-NMR Naggi et al., 1989) measurements.
In particular, 13 C-NMR showed that sulphation at the C-6 of N-acetylgalactosamine shifted the C-6 signal from approximately 62 to approximately 69 p.p.m. In DS type compounds, sulphation, presumably at the C-2 of iduronic acid, shifted the signal of C-1 from approximately 104.5 to approximately 101.5 p.p.m. In CS type compounds, sulphation of the glucuronic acid moiety shifted the C-1 signal from approximately 106.5 to approximately 103 p.p.m., both in CS 4-and CS 6-sulphate.
Chemical oversulphation of the present DS type compounds occurred primarily at the C-6 of N-acetylgalactosamine, which proved to be more than 90% sulphated both in compounds 10 and 14.
Materials and Methods: Virology

Evaluation of cell toxicity
The toxicity of the compounds to C8166 T lymphocytes and to phytohaemoagglutinin (PHA)-activated peripheral blood mononuclear cells (PBMC) was assessed by measuring the viability of the cells treated with the drugs for 96 h and 8 days, respectively. The number of viable cells was evaluated spectrophotometrically by measurement of the in situ reduction of yellow-coloured 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide by mitochondrial dehydrogenases of surviving metabolically active cells to a blue formazan (MTT assay) (Pauwels et al., 1988) . The toxicity of the compounds to Vero cells and human embryo lung (HEL) fibroblasts was evaluated microscopically according to the maintenance of normal morphology in the cultures treated for 72 h.
Cytotoxicity is expressed as CC 50 (the concentration of the compounds that causes a 50% reduction in the viability of the mock-infected cells used as host cells for the infection).
Evaluation of antiviral activity
The anti-HIV-1 activity of the compounds was evaluated in C8166 T lymphocytes (2×10 5 cells/ml/well) suspended in RPMI 1640 medium containing the compounds at various concentrations. After 30 min of incubation at 37°C in 5% CO 2 , the cultures were treated with HIV-1 IIIB (m.o.i. 0.1) and re-incubated. After 2 h the medium was removed and the cells were repeatedly washed and resuspended in RPMI 1640 medium containing different concentrations of the compounds. The infected cultures were observed over time for the appearance of syncytia and single cell lysis. HIV-1 production was evaluated by measuring viral p24 (Vironostika HIV-1, Antigen Microelisa System, Organon Teknika) that accumulated in the culture medium after 96 h, the time of maximum viral accumulation without appreciable cell death.
The anti-HIV-1 activity was also measured in PBMC, by infecting the cells either with HIV-1 IIIB or with a syncytium-inducing strain of HIV-1 (SI 19 ), isolated from an AIDS patient. PBMC from three healthy donors were suspended in RPMI 1640 medium containing PHA (2 µg/ml) and incubated at 37°C in 5% CO 2 for 48 h. The PHA-activated cultures were infected with HIV-1 strains after a pre-treatment (30 min) with various concentrations of the compounds. The infection was carried out by adding a dose of each viral strain corresponding to 20 ng of p24 antigen to the cultures (2×10 6 cells/ml/well). After 2 h of incubation at 37°C the cells were extensively washed and resuspended in fresh RPMI 1640 medium containing various concentrations of the compounds. HIV-1 production was evaluated by measuring viral p24 accumulated in the media, collected 8 days after infection.
The anti-HSV-1 activity of the compounds was assayed as follows: confluent Vero cell monolayers, grown in 1 ml 24-well plates (6×10 5 cells/ml/well) were overlayed with 1 ml of RPMI 1640 medium (BIO-Whittaker) containing 10% foetal calf serum (FCS; Biological Industries, Haemek, Israel) supplemented with various concentrations of the compounds. After 30 min of incubation at 37°C, 100 p.f.u. of HSV-1 gs, a clinical isolate obtained from the oral mucosa of a patient affected by acute gingivostomatitis, were added to each monolayer and the cultures were reincubated. After 1 h at 37°C, the media were removed and the cultures were again overlaid with RPMI 1640 medium plus 10% FCS containing the compounds at various concentrations and 1% pooled human sera positive for anti HSV-1 antibodies. After 3 days of incubation at 37°C, the monolayers were fixed and stained with Giemsa for the evaluation of the plaque number in each culture.
The anti-HSV-1 activity was also assayed, as above, on HSV-1 strain hl, another clinical isolate from vesicles of recurrent herpes labialis.
The anti-HCMV activity of the compounds was evaluated in HEL fibroblast monolayers. The cultures were pretreated with different concentrations of the compounds, and infected with the amount of HCMV (AD169 standard strain), giving 100 infected nuclei per well, determined by indirect immunofluorescence with anti-HCMV pp65 MAb (Argene Biosoft, Varhiles, France), (Gerna et al., 1990) . After exposing the cells to infection for 1 h, the virus was removed and a fresh culture medium, containing the compounds at various concentrations, was added. Following incubation at 37°C for 24 h, inoculated cell cultures were fixed with methanol:acetone (1: 2) and stained for indirect immunofluorescence with anti-HCMV pp65 MAb. The anti-HCMV activity was also assayed as above, by infecting HEL fibroblasts with a clinical strain of HCMV (cl1) isolated from an immunosuppressed patient.
The compounds were tested twice at concentrations of 0.01, 0.1, 1 and 10 µg/ml. Antiviral activity was expressed as the EC 50 (the concentration inhibiting virus replication by 50%); HIV-1 was tested in C8166 T cells and PBMC, HSV-1 in Vero cells and HCMV in HEL fibroblasts. EC 50 values were estimated by interpolation of the data.
Cell cultures infected in the absence of the compounds under study were used as controls.
Evaluation of the anti-haemocoagulative effects
The activated partial thromboplastin time (APTT) activity (U/mg) was measured against the fourth WHO international standard of heparin (193.4 U/mg). The curves of the standard and of the galactosaminoglycans were not parallel, therefore the calculation was performed by comparing b of the regression lines, according to Thomson & Poller (1985) . Table 1 reports the origin, type, molecular mass and sulphation index of the natural glycosaminoglycans under study together with those of their oversulphated products obtained either by drastic or mild chemical sulphation. A wide range of molecular masses (from 10.1 to 45 kDa) and degrees of sulphation (averaging from approximately 1 to 3.20 sulphate groups per disaccharide unit) were covered, thus allowing for an evaluation of the influence of these parameters on the antiviral activity of the examined compounds. One fraction of dextran sulphate and one fraction of heparin were also included for comparison.
Results
All tested compounds were not toxic for all cellular systems employed in this study at concentrations up to 100 µg/ml (Tables 2 and 3) .
As can be seen in Table 2 , a strong anti-HIV-1 IIIB activity (EC 50 ≤ 1 µg/ml) characterized the derivatives 2, 4, 7, 8 and 14. In particular the EC 50 of 14 (EC 50 0.04 µg/ml) was 10-fold lower than that of the reference compounds 15 and 
0.5 >100 0.5 (0.1) >100 0.6 (0.2) >100 0.6 (0.2) † 0.5 (0.2) ‡ EC 50 values and CC 50 values are given in µg/ml. *Deviation of two determinations in parentheses. †Value obtained by infecting Vero cells with HSV-1 strain hl. ‡Value obtained by infecting HEL fibroblasts with HCMV strain cl1. 
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The anti-HIV-1 activity of compound 14 and of 16 (heparin) as reference, was also evaluated in a different cell culture, PBMC, infected either with the standard IIIB strain or with strain SI 19 isolated from an AIDS patient (Table 3) . As found in C8166 T cells, the antiviral activity of compound 14 was also significantly higher than that of heparin (16) in PBMC. Moreover, the activity of both compounds was lower against the clinical isolate SI 19 than against the standard IIIB strain.
The oversulphated compounds 2, 4, 7, 8, 10 and 14 showed strong activities against HSV-1 gs. The EC 50 values of compounds 2, 4, 7, 8 and 14 were similar to those found with the reference compounds 15 and 16, and that of 10 was even lower (EC 50 0.01 µg/ml).
Compound 10 was also tested on another HSV-1 strain, clinical isolate HIV-1 hl, and showed the same level of activity (Table 2) . A smaller number of compounds, 2, 7 and 14, showed levels of anti-HCMV AD169 activity comparable to those found with the reference compounds 15 and 16 (EC 50 ≤1 µg/ml), the EC 50 of 7 being the lowest (0.4 µg/ml).
Compound 7 was also tested on another HCMV strain, clinical isolate cl1 and showed the same level of activity (Table 2) .
With reference to the spectrum of antiviral activity, in detail, the six derivatives 2, 4, 7, 8, 10, 14 , with a sulphation index ≥2.40 (Table 1) , were the most potent inhibitors against all three types of viruses (Tables 2 and 3) , demonstrating a clear relationship between this parameter and the biological activity of these compounds. Among these six compounds, 10, which had both the lowest sulphation index (2.40) and the highest molecular mass (25.0 kDa), was the most potent inhibitor of HSV-1 infectivity. It was also a potent inhibitor of HIV-1 and HCMV. On the other hand, compound 2 for example, which had the highest sulphation index (3.20) but a comparatively lower molecular mass (11.7 KDa), was less potent than 10 on HSV-1, 14 and 8 (sulphation index 2.86 and 2.66, and molecular mass 23.0 and 17.9 kDa, respectively) on HIV-1, and 7 (sulphation index 2.80 and molecular weight 17.3 KDa) on HCMV.
To summarize, among the present compounds, oversulphated DS 10 and 14 displayed the highest levels of activity in vitro. The former is a very potent inhibitor of HSV-1, with an EC 50 of 0.01 µg/ml, whereas the latter displays an EC 50 of 0.04 µg/ml against HIV-1. Oversulphated CS 7 was the most active against HCMV, with an EC 50 of 0.4 µg/ml. The overall activities of all compounds 2, 4, 7, 8, 10 and 14 are promising, their EC 50 being ≤1 µg/ml against HIV-1 and HSV-1 and ≤3 µg/ml against HCMV. Table 4 reports the APTT activity, as a measurement of the anti-haemocoagulative power of the compounds under study. The APTT activities of the natural, sulphated compounds were all lower than 1 U/mg. Those of the oversulphated compounds were higher, but still much lower than that of heparin (170 U/mg). The highest values were found with compounds 7 and 8 (46.2 and 38.1 U/mg respectively), two oversulphated CS samples with a high degree of sulphation (Table 1) . It can be hypothesized that the higher APTT activity is due to the formation and/or to an increase in the number of peculiar clusters of trisulphate disaccharides in the long chain oversulphated CS. In fact, 2,4-and 2,6-disulphate disaccharides, in which the uronic acid is sulphated at C-2, were already present in CS from shark cartilage (Bartolucci et al., 1995) , from which 7 and 8 were derived.
Discussion
The data reported in Tables 2 and 3 show that the naturally occurring CS and DS, with sulphation indexes between 1.06 and 1.25, do not display any relevant antiviral activity. However, their oversulphation yields potent in vitro inhibitors of both DNA and RNA enveloped viruses, with an increase in antiviral activity ranging from one to four orders of magnitude.
The inhibitory power of the examined compounds seems to be mainly dependent on the appropriate combination of two parameters, molecular mass and number of charged groups, proportional to the sulphation index, as previously observed for other polyanions.
No apparent relationship emerges between the nature of the sugar backbone and the antiviral activity. A higher conformational flexibility has been invoked to explain the higher activity of DS compared to CS in some biological contexts (Venkataraman et al., 1994) . In this case, the importance of this parameter seems to be clearly overcome by those of charge and molecular mass.
The inhibitory activity of these types of compounds is believed to arise from their binding to the glycoproteins of Antiviral Chemistry & Chemotherapy 10:1 Bartolucci et al. (1995) . † APTT (U/mg) in comparison with the IV International WHO Heparin Standard (193.4 U/mg).
Antiviral oversulphated galactosaminoglycans
the viral envelope, which recognize the host cell surface receptors, thus hindering the initiation of the infectious process.
As for HIV, some reports support the hypothesis of the specific binding of sulphated polysaccharides to the HIV gp120 V3 loop (Harrop et al., 1998; Witvrouw et al., 1997) .
In conclusion, these oversulphated galactosaminoglycans have shown high antiviral activity in vitro and neither toxicity, nor appreciable heparin-like side-effects, at concentrations much higher than their antiviral EC 50 . In addition, these types of compounds are known to give rise to low levels of resistance.
The present comparative data in terms of viruses and chemical structures provide interesting tools for the investigation of the area of virus-cell interactions.
It can be hypothesized that compounds like 2, 7, 10, and 14 in particular, their associations and combinations with other types of drugs, could be important against HIV-1infection and against HSV-1 and HCMV, well-known agents of opportunistic infections in HIV-infected people.
It can be speculated as to whether such large and complicated molecules would make it through the clinic for systemic treatment. Further investigations into the spectrum of action, in vivo activity, pharmacokinetics and toxicology of these compounds will be needed to get a clear view of their pharmacological potential.
